Screener
Relay Therapeutics, Inc. RLAY Other Income Expense
Other Income Expense at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlay:OtherIncomeExpense.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (90,824) | (76,847) | (169,414) | (161,717) |
| Other income: | ||||
| Interest income | 7,115 | 7,105 | 12,467 | 14,918 |
| Other income (expense) | 2 | (633) | (51) | (641) |
| Total other income, net | 7,117 | 6,472 | 12,416 | 14,277 |
| Net loss | $(83,707) | $(70,375) | $(156,998) | $(147,440) |
| Net loss per share, basic and diluted | $(0.41) | $(0.41) | $(0.82) | $(0.87) |
| Weighted average shares of common stock, basic and diluted | 202,849,466 | 171,264,622 | 191,412,839 | 170,254,500 |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s other income expense?
- Relay Therapeutics, Inc. (RLAY) reported other income expense of $2K in Q2 2026.
- How has Relay Therapeutics, Inc.'s other income expense changed year-over-year?
- Relay Therapeutics, Inc.'s other income expense increased by 100.3% year-over-year, from -$633K to $2K.
- What is the long-term trend for Relay Therapeutics, Inc.'s other income expense?
- Over 3 years (2022 to 2025), Relay Therapeutics, Inc.'s other income expense has grown at a 243.0% compound annual growth rate (CAGR), from -$20K to -$807K.
- What does other income expense mean?
- This line item captures miscellaneous financial activities that fall outside of core operating revenues and expenses, such as gains or losses from asset disposals, foreign currency fluctuations, or non-recurring legal settlements. It provides a view into peripheral financial impacts that influence the bottom line but are not directly tied to the primary business operations. Monitoring this helps investors isolate core operational performance from transient or non-core financial events.
Ask your AI about Relay Therapeutics, Inc.'s other income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude